For some cancers, survival rates are now 90%. But for harder-to-treat cancers, just five out of 10 children survive.

The situation today

While cancer in childhood is very rare, it’s still the most common cause of death in children under the age of 14 – around 250 children lose their lives to the disease every year. 

GOSH has the biggest children’s cancer unit in the UK and our researchers have helped to dramatically improve survival rates for young people in the past 40 years. But we need to help find more answers for children with the most difficult-to-treat cancers.

As a result of investment in research and treatment, survival has increased dramatically, and now more than 75 per cent of children survive for 10 years or more. 

How we’ll help shape the future

Our researchers will pioneer personalised treatments for high-risk brain cancers, chemotherapy-resistant leukaemias and recurring tumours.

They’ll focus on understanding the genetic profile of a child’s cancer, so doctors can match young patients to the clinical trials and treatments most likely to work for them. This approach means fewer unnecessary side effects, so children have a better quality of life now and as an adult.